<DOC>
	<DOCNO>NCT02034877</DOCNO>
	<brief_summary>This study describe safety immunogenicity 13vPnC Indian adult 50 65 year age Indian child 6 17 year age .</brief_summary>
	<brief_title>13-valent Pneumococcal Conjugate Vaccine Study Adults Children India</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Indian adult subject 50 65 year age indian child 6 17years age , determine clinical judgment eligible 13vPnC vaccination . Any contraindication 13vPnC vaccination , vaccination pneumococcal vaccine within last year</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>13-valent pneunococcal conjugate vaccine</keyword>
	<keyword>pneumococcal disease prevention ; safety immunogenicity study</keyword>
</DOC>